NYX Nyse Euronext

NYSE Euronext (NYX) today announced trading volumes for its global derivatives and cash equities exchanges for October 20101. Global derivatives average daily volume (“ADV”) of 7.5 million contracts traded per day in October 2010 increased 6.2% versus the prior year, but decreased 2.9% from September 2010 levels. The increase in global derivatives ADV versus prior year levels was driven by a 23.8% increase in U.S. equity options ADV, partially offset by an 8.4% decrease in European derivatives ADV. Cash equities ADV in October 2010 were down year-over-year, but both European and U.S. cash trading volumes increased from September 2010 levels by 3.0% and 3.8%, respectively.

Highlights

• NYSE Euronext global derivatives ADV in October 2010 of 7.5 million contracts increased 6.2% compared to October 2009, but decreased 2.9% from September 2010 levels. Open interest for our European derivatives businesses at the end of October 2010 was 82.0 million contracts, a decrease of 5.5% compared to October 2009, but an increase of 6.7% from September 2010 levels.
• NYSE Euronext European derivatives products ADV in October 2010 of 3.5 million contracts decreased 8.4% compared to October 2009 and decreased 16.3% from September 2010 levels. Total European fixed income products ADV in October 2010 of 2.0 million contracts increased 0.2% compared to October 2009, but decreased 10.4% from September 2010. Total equity products ADV of 1.5 million contracts in October 2010 decreased 19.1% compared to October 2009 and decreased 23.7% from September 2010. Total commodities products ADV of 76,000 contracts in October 2010 increased 36.4% compared to October 2009.
• NYSE Euronext U.S. equity options (NYSE Arca and NYSE Amex) ADV of 3.9 million contracts in October 2010 increased 23.8% compared to October 2009 levels and increased 13.5% from September 2010. NYSE Euronext’s U.S. options exchanges accounted for 25.9% of the total consolidated equity options trading in October 2010, up from 22.8% in October 2009, but below the 26.1% recorded in September 2010.
• NYSE Euronext European cash products ADV of 1.4 million transactions in October 2010 decreased 8.8% compared to October 2009, but increased 3.0% from September 2010.
• NYSE Euronext U.S. cash products (NYSE, NYSE Arca and NYSE Amex) handled ADV of 2.4 billion shares in October 2010 decreased 19.1% compared to October 2009, but increased 3.8% compared to September 2010. NYSE Euronext’s Tape A matched market share in October 2010 was 35.2%, down from 36.6% in October 2009 and down from 38.4% in September 2010.
• There were a total of 21 trading days in Europe and the U.S. in October 2010 and 22 trading days in Europe and the U.S. in October 2009.

Derivatives Trading

European Derivatives

• NYSE Euronext European derivatives products ADV in October 2010 was 3.5 million futures and options contracts, a decrease of 8.4% from October 2009 and a decrease of 16.3% from September 2010. The 3.5 million in futures and options contracts ADV in October 2010 consisted of 3.1 million contracts executed through our full-service LIFFE CONNECT trading platform and 0.5 million contracts, or 13.6%, executed through Bclear, NYSE Liffe's trade administration and clearing service for OTC products.
• Year-to-date, European derivatives products ADV of 4.9 million contracts was 19.7% above prior year levels. The 4.9 million in futures and options contracts ADV year-to-date consisted of 3.6 million contracts executed through the LIFFE CONNECT trading platform and 1.4 million contracts, or 28.0%, executed through Bclear.
• Total fixed income products ADV of 2.0 million contracts in October 2010 increased 0.2% from October 2009, but decreased 10.4% from September 2010. Year-to-date, total fixed income products ADV of 2.4 million contracts was 18.8% above prior year levels.
• Total equity products (including Bclear) ADV of 1.5 million contracts in October 2010 decreased 19.1% compared to October 2009 and decreased 23.7% from September 2010. The 1.5 million contracts in equity products ADV consisted of 1.0 million contracts in individual equity products ADV and 0.5 million contracts in equity index products ADV. The 1.0 million contracts in individual equity products ADV consisted of 0.3 million in futures contracts, which represented a 10.1% decrease compared to October 2009 and 0.6 million in options contracts, which represented a 23.1% decrease compared to October 2009. The average rate per contract for individual equity futures contracts is significantly lower than other products traded on NYSE Liffe. Year-to-date, total equity products ADV of 2.5 million contracts was 20.3% above prior year levels.
• Total commodities products ADV of 76,000 contracts in October 2010 increased 36.4% compared to October 2009. Year-to-date, total commodities product ADV of 64,000 contracts was 34.4% above prior year levels.

U.S. Derivatives

• NYSE Euronext U.S. equity options (NYSE Arca and NYSE Amex) ADV of 3.9 million contracts in October 2010 increased 23.8% compared to October 2009 and increased 13.5% compared to September 2010. Year-to-date, U.S. equity options ADV of 3.7 million contracts was 43.8% above prior year levels.
• Total U.S. consolidated equity options ADV increased 9.0% to 15.2 million contracts in October 2010 compared to October 2009 and increased 14.1% compared to September 2010. Year-to-date, U.S. consolidated equity options ADV of 14.2 million contracts was 4.3% above prior year levels.
• NYSE Euronext’s U.S. options exchanges accounted for 25.9% of the total U.S. consolidated equity options trading in October 2010, up from 22.8% in October 2009, but down from 26.1% in September 2010.
• NYSE Euronext U.S. futures and futures options (NYSE Liffe U.S.) ADV in October 2010 was approximately 12,900 contracts, compared to 22,100 contracts in October 2009. Year-to-date U.S. futures and futures options ADV was 16,200 contracts, a decrease of 5.2% compared to the prior year period.

Cash Trading

European Cash

• NYSE Euronext European cash products ADV of 1.4 million transactions in October 2010 decreased 8.8% compared to October 2009, but increased 3.0% compared to September 2010.
• Year-to-date, European cash products ADV of 1.5 million transactions was 5.5% above prior year levels.

U.S. Cash

• NYSE Euronext U.S. cash products handled ADV in October 2010 decreased 19.1% to 2.4 billion shares compared to October 2009, but increased 3.8% from September 2010.
• Year-to-date, U.S. cash products handled ADV was 2.7 billion shares, down 22.4% from prior year levels.
• NYSE Euronext’s Tape A matched market share in October 2010 was 35.2%, down from 36.6% in October 2009 and down from 38.4% in September 2010.
• Designated Market Maker participation in NYSE-listed stocks in October 2010 was 9.6%, compared to 9.4% in September 2010 and 9.8% in August 2010. Supplemental Liquidity Provider participation in NYSE-listed stocks in October 2010 was 15.4%, compared to 12.4% in September 2010 and 12.2% in August 2010. DMM and SLP participation pertain only to trading on NYSE.

Exchange Traded Products

• NYSE Euronext U.S. matched exchange-traded products ADV (included in volumes for Tape B and Tape C) of 302 million shares in October 2010 decreased 12.8% compared to October 2009 and was flat compared to September 2010. Year-to-date, NYSE Euronext U.S. matched exchange-traded products ADV of 347 million shares was 26.6% below prior year levels.

Please click here for the Monthly Transaction Activity Data Table.

About NYSE Euronext

NYSE Euronext (NYX) is a leading global operator of financial markets and provider of innovative trading technologies. The company's exchanges in Europe and the United States trade equities, futures, options, fixed-income and exchange-traded products. With approximately 8,000 listed issues (excluding European Structured Products), NYSE Euronext's equities markets – the New York Stock Exchange, NYSE Euronext, NYSE Amex, NYSE Alternext and NYSE Arca – represent one-third of the world's equities trading, the most liquidity of any global exchange group. NYSE Euronext also operates NYSE Liffe, one of the leading European derivatives businesses and the world's second-largest derivatives business by value of trading. The company offers comprehensive commercial technology, connectivity and market data products and services through NYSE Technologies. NYSE Euronext is in the S&P 500 index, and is the only exchange operator in the S&P 100 index and Fortune 500. For more information, please visit: http://www.nyx.com.

Cautionary Note Regarding Forward-Looking Statements

This press release August contain forward-looking statements, including forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements include, but are not limited to, statements concerning NYSE Euronext’s plans, objectives, expectations and intentions and other statements that are not historical or current facts. Forward-looking statements are based on NYSE Euronext’s current expectations and involve risks and uncertainties that could cause actual results to differ materially from those expressed or implied in such forward-looking statements. Factors that could cause NYSE Euronext’s results to differ materially from current expectations include, but are not limited to: NYSE Euronext’s ability to implement its strategic initiatives, economic, political and market conditions and fluctuations, government and industry regulation, interest rate risk and U.S. and global competition, and other factors detailed in NYSE Euronext’s reference document for 2009 ("document de référence") filed with the French Autorité des Marchés Financiers (Filed on April 22, 2010 under No. D.10-0304), 2009 Annual Report on Form 10-K and other periodic reports filed with the U.S. Securities and Exchange Commission or the French Autorité des Marchés Financiers. In addition, these statements are based on a number of assumptions that are subject to change. Accordingly, actual results August be materially higher or lower than those projected. The inclusion of such projections herein should not be regarded as a representation by NYSE Euronext that the projections will prove to be correct. This press release speaks only as of this date. NYSE Euronext disclaims any duty to update the information herein.

1 All NYSE Euronext derivatives transactions count buy and sell orders together as a single transaction. NYSE Euronext European equities transactions count each buy and sell order as separate transactions, NYSE Euronext U.S. equities transactions count buy and sell orders together as a single transaction.

NYSE Euronext

Monthly Volume Summary

                        Average Daily Volume Total Volume Average Daily Volume Total Volume % Chg vs. % Chg vs. (Unaudited) Oct-10 Oct-09 % Chg Oct-10 Oct-09 % Chg YTD 2010 YTD 2009 YTD 2010 YTD 2009   Number of Trading Days - European Markets 21 22 21 22 213 213 Number of Trading Days - U.S. Markets 21 22 21 22 209 209   European Derivatives Products (contracts in thousands) 3,548 3,871 -8.4 % 74,502 85,173 -12.5 % 4,931 19.7 % 1,050,401 19.7 % of which Bclear 482 604 -20.2 % 10,116 13,285 -23.8 % 1,381 35.0 % 294,125 35.0 %   Total Fixed Income Products 1,997 1,992 0.2 % 41,934 43,824 -4.3 % 2,393 18.8 % 509,638 18.8 %   Short Term Interest Rate Products 1,880 1,881 0.0 % 39,485 41,376 -4.6 % 2,276 19.0 % 484,866 19.0 % Medium and Long Term Interest Rate Products 1 117 111 4.8 % 2,450 2,448 0.0 % 116 16.0 % 24,772 16.0 %   Total Equity Products 2 1,475 1,824 -19.1 % 30,965 40,118 -22.8 % 2,474 20.3 % 527,032 20.3 %   Individual Equity Products 969 1,197 -19.0 % 20,355 26,332 -22.7 % 1,861 29.3 % 396,401 29.3 % Futures 340 378 -10.1 % 7,132 8,310 -14.2 % 1,174 50.3 % 250,112 50.3 % Options 630 819 -23.1 % 13,223 18,021 -26.6 % 687 4.5 % 146,288 4.5 % Equity Index Products 505 627 -19.4 % 10,610 13,786 -23.0 % 613 -0.8 % 130,631 -0.8 %   of which Bclear 482 604 -20.2 % 10,116 13,285 -23.8 % 1,381 35.0 % 294,125 35.0 % Individual Equity Products 412 475 -13.3 % 8,658 10,461 -17.2 % 1,285 44.2 % 273,727 44.2 % Futures 337 378 -10.9 % 7,068 8,306 -14.9 % 1,170 50.9 % 249,167 50.9 % Options 76 98 -22.7 % 1,590 2,154 -26.2 % 115 -0.6 % 24,559 -0.6 % Equity Index Products 69 128 -45.9 % 1,459 2,824 -48.4 % 96 -27.2 % 20,399 -27.2 %   Commodity Products 76 56 36.4 % 1,603 1,230 30.2 % 64 34.4 % 13,731 34.4 %   U.S. Derivatives Products (contracts in thousands)   Equity Options 3   NYSE Euronext Options Contracts 3,942 3,185 23.8 % 82,791 70,074 18.1 % 3,681 43.8 % 769,396 43.1 % Total Consolidated Options Contracts 15,199 13,942 9.0 % 319,169 306,729 4.1 % 14,157 4.3 % 2,958,718 3.8 %   NYSE Group Share of Total 25.9 % 22.8 % 25.9 % 22.8 % 26.0 % 7.1 % 26.0 % 7.1 %   NYSE Liffe U.S.   Futures and Futures Options Volume 12.9 22.1 -41.3 % 272 485 -44.0 % 16.2 -5.2 % 3,394.4 -5.7 %   European Cash Products (trades in thousands) 1,441 1,580 -8.8 % 30,252 34,758 -13.0 % 1,479 5.5 % 314,985 5.5 %   Equities 1,382 1,516 -8.8 % 29,027 33,358 -13.0 % 1,420 5.7 % 302,375 5.7 % Exchange-Traded Funds 17 17 -2.5 % 352 378 -6.9 % 18 23.2 % 3,784 23.2 % Structured Products 36 40 -9.8 % 760 883 -13.9 % 36 -8.8 % 7,605 -8.8 % Bonds 5 6 -15.0 % 113 139 -18.9 % 6 1.0 % 1,221 1.0 %   U.S. Cash Products (shares in millions) 5 2,364 2,922 -19.1 % 49,646 64,279 -22.8 % 2,684 -22.4 % 560,871 -22.8 %   NYSE Listed (Tape A) Issues 4   Handled Volume 5 1,703 2,147 -20.7 % 35,755 47,238 -24.3 % 1,945 -23.0 % 406,530 -23.3 % Matched Volume 6 1,612 1,972 -18.3 % 33,857 43,389 -22.0 % 1,824 -20.4 % 381,232 -20.8 % Total NYSE Listed Consolidated Volume 4,577 5,388 -15.0 % 96,126 118,535 -18.9 % 5,005 -15.6 % 1,046,089 -16.0 %   Share of Total Consolidated Volume Handled Volume 5 37.2 % 39.9 % -2.7 % 37.2 % 39.9 % -2.7 % 38.9 % -3.7 % 38.9 % -3.7 % Matched Volume 6 35.2 % 36.6 % -1.4 % 35.2 % 36.6 % -1.4 % 36.4 % -2.2 % 36.4 % -2.2 %   NYSE Arca & Amex (Tape B) Listed Issues   Handled Volume 5 346 418 -17.1 % 7,276 9,189 -20.8 % 400 -27.2 % 83,520 -27.6 % Matched Volume 6 315 365 -13.8 % 6,610 8,034 -17.7 % 359 -25.2 % 75,016 -25.6 % Total NYSE Arca & Amex Listed Consolidated Volume 1,268 1,625 -21.9 % 26,628 35,741 -25.5 % 1,507 -24.6 % 315,033 -25.0 %   Share of Total Consolidated Volume Handled Volume 5 27.3 % 25.7 % 1.6 % 27.3 % 25.7 % 1.6 % 26.5 % -1.0 % 26.5 % -1.0 % Matched Volume 6 24.8 % 22.5 % 2.3 % 24.8 % 22.5 % 2.3 % 23.8 % -0.2 % 23.8 % -0.2 %   Nasdaq Listed (Tape C) Issues   Handled Volume 5 315 357 -11.7 % 6,615 7,852 -15.8 % 339 -12.3 % 70,821 -12.7 % Matched Volume 6 272 288 -5.7 % 5,705 6,339 -10.0 % 286 -9.3 % 59,725 -9.7 % Total Nasdaq Listed Consolidated Volume 2,015 2,335 -13.7 % 42,318 51,363 -17.6 % 2,266 -1.6 % 473,617 -2.0 %   Share of Total Consolidated Volume Handled Volume 5 15.6 % 15.3 % 0.3 % 15.6 % 15.3 % 0.3 % 15.0 % -1.8 % 15.0 % -1.8 % Matched Volume 6 13.5 % 12.3 % 1.2 % 13.5 % 12.3 % 1.2 % 12.6 % -1.1 % 12.6 % -1.1 %   Exchange-Traded Funds 5,7   Handled Volume 5 286 395 -27.5 % 6,015 8,697 -30.8 % 381 -29.3 % 79,622 -29.7 % Matched Volume 6 302 346 -12.8 % 6,348 7,623 -16.7 % 347 -26.6 % 72,520 -26.9 % Total ETF Consolidated Volume 1,231 1,592 -22.7 % 25,842 35,029 -26.2 % 1,489 -26.2 % 311,245 -26.6 %   Share of Total Consolidated Volume Handled Volume 5 23.3 % 24.8 % -1.5 % 23.3 % 24.8 % -1.5 % 25.6 % -1.1 % 25.6 % -1.1 % Matched Volume 6 24.6 % 21.8 % 2.8 % 24.6 % 21.8 % 2.8 % 23.3 % -0.1 % 23.3 % -0.1 %    

1 

Data includes currency products.

2 

Includes all trading activities for Bclear, NYSE Liffe's clearing service for wholesale derivatives.

3 

Includes trading in U.S. equity options contracts, not equity-index options.

4 

Includes all volume executed in NYSE Group crossing sessions.

5 

Represents the total number of shares of equity securities and ETFs internally matched on the NYSE Group's exchanges or routed to and executed at an external market center. NYSE Arca routing includes odd-lots.

6 

Represents the total number of shares of equity securities and ETFs executed on the NYSE Group's exchanges.

7 

Data included in previously identified categories. Source: NYSE Euronext, Options Clearing Corporation and Consolidated Tape as reported for equity securities. All trading activity is single-counted, except European cash trading which is double counted to include both buys and sells.